entrezID,gene_symbol,biotype,bioproject,res_design,host_type,stimulator,concentration,H.P.S,baseMean,log2FoldChange,lfcSE,stat,pvalue,padj,cell_type
441391,RBMXP2,pseudogene,PRJNA474093,IFN-beta stimulation vs. mock stimulation,immortalized human hepatocytes PH5CH8,IFN-beta,N.A.,12,20.1617168236481,-0.449504930101373,0.459390866858605,-0.978480336744975,0.327836811847839,0.864175487816573,NA
441391,RBMXP2,pseudogene,PRJNA565586,IFN-gamma stimulation vs. mock stimulation,NA,IFN-gamma,100U/ml,24,25.8294876045141,0.184558271091106,0.360697450884763,0.511670572216129,0.608881585012988,0.96308222060722,patient-derived GBM cell lines (PDGCLs)
441391,RBMXP2,pseudogene,PRJNA667475,IFN-beta stimulation vs. mock stimulation,NA,IFN-beta,250U/ml,8,3.52444416776783,1.09417520932479,1.1695768119235,0.935530867378687,0.349514783415096,0.763197143921981,A549
441391,RBMXP2,pseudogene,PRJNA739760,INF-alpha2 stimulation (with DMSO) vs. mock stimulation (with DMSO),NA,IFN-alpha,1000U/ml,16,17.0121210439519,0.220116649781603,0.477815961315447,0.460672450488285,0.645033623278254,0.986418245486816,A549
441391,RBMXP2,pseudogene,PRJNA768480,IFN-gamma stimulation vs. mock stimulation,NA,IFN-gamma,N.A.,N.A.,16.6494834549242,0.0108527222157609,0.756795709819809,0.0143403590624806,0.988558441060632,0.991856585424167,A549
441391,RBMXP2,pseudogene,PRJNA788896,IFN-beta stimulation vs. mock stimulation,NA,IFN-beta,N.A.,N.A.,21.9651185030966,0.149520647399148,0.356893566047518,0.418950246301835,0.675252494318769,1,sigmoid colon organoid
441391,RBMXP2,pseudogene,PRJNA788896,IFN-beta stimulation vs. mock stimulation,NA,IFN-beta,N.A.,N.A.,21.9651185030966,0.291342572188021,0.351313548766717,0.829295007866267,0.406937495035615,1,sigmoid colon organoid
